New tool matches microbial and metabolic metaproteomic data
Metaproteomics is the study of all proteins expressed in entire communities, such as soil and gut microbiomes, and often requires bioinformatics approaches to analyze large quantities of data. However, until recently, none of these tools mapped protein or peptide data onto information about their biological functions.

To address this gap, in a recent study in Molecular & Cellular Proteomics, Tibo Vande Moortele of Ghent University and an international team of researchers created PathwayPilot. This bioinformatics resource combines proteomic data, including protein identification and abundances, with metabolic pathway data. Users can upload peptide or protein data, choose their desired pathways for analysis and export the results in various formats for further analysis. This makes it easier for researchers to identify the biochemical functions of proteins between organisms in a microbial community or between communities. The team tested PathwayPilot’s accuracy by analyzing data from a study on lipid metabolism and found that nearly all results matched to a known pathway.
Researchers can use this tool to compare the metaproteomic effects of environmental factors such as temperature or determine the role of a microorganism in its community, with promising applications in medical microbiology and ecology. PathwayPilot currently can only be used to compare two groups, so the team plans to continue updating the resource.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

How sugars shape Marfan syndrome
Research from the University of Georgia shows that Marfan syndrome–associated fibrillin-1 mutations disrupt O glycosylation, revealing unexpected changes that may alter the protein's function in the extracellular matrix.

What’s in a diagnosis?
When Jessica Foglio’s son Ben was first diagnosed with cerebral palsy, the label didn’t feel right. Whole exome sequencing revealed a rare disorder called Salla disease. Now Jessica is building community and driving research for answers.

Peer through a window to the future of science
Aaron Hoskins of the University of Wisconsin–Madison and Sandra Gabelli of Merck, co-chairs of the 2026 ASBMB annual meeting, to be held March 7–10, explain how this gathering will inspire new ideas and drive progress in molecular life sciences.

Glow-based assay sheds light on disease-causing mutations
University of Michigan researchers create a way to screen protein structure changes caused by mutations that may lead to new rare disease therapeutics.

How signals shape DNA via gene regulation
A new chromatin isolation technique reveals how signaling pathways reshape DNA-bound proteins, offering insight into potential targets for precision therapies. Read more about this recent MCP paper.

A game changer in cancer kinase target profiling
A new phosphonate-tagging method improves kinase inhibitor profiling, revealing off-target effects and paving the way for safer, more precise cancer therapies tailored to individual patients. Read more about this recent MCP paper.